Skip to main content

Boxer Capital Management, LLC

13F filer · CIK 0002018299
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$1.33BU.S. long equity reported on 13F
Positions6212 new · 3 closed
Net flow last quarter+$311MBuys minus sells
Top 10 positions weight65.1%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202662 positions
TNGXTango Therapeutics, Inc.$340M25.61%6.46%Not reportedQ4 2024
RVMDRevolution Medicines, Inc.$93.6M7.05%0.23%Not reportedQ4 2024
ABVXAbivax S.A.$80.6M6.07%0.77%+202.5%Q3 2025
QUREuniQure N.V.$69.2M5.21%2.17%+127.1%Q4 2024
KODKodiak Sciences Inc.$57.6M4.34%2.35%+8.6%Q4 2024
KYMRKymera Therapeutics, Inc.$49.2M3.71%0.52%+30.4%Q4 2024
DFTXDefinium Therapeutics, Inc.$47M3.54%0.74%+66.8%Q1 2026
REPLReplimune Group, Inc.$44.1M3.32%4.74%+239.0%Q4 2024
CELCCelcuity Inc.$43.6M3.28%0.85%+85.1%Q3 2025
QTTBQ32 Bio Inc.$40.1M3.02%13.27%NewQ2 2026
CAPRCapricor Therapeutics, Inc.$33.6M2.53%2.40%+136.5%Q4 2025
PGENPrecigen, Inc.$29.4M2.21%1.44%+47.1%Q3 2025
CORTCorcept Therapeutics Inc$29.2M2.20%0.31%+34.2%Q1 2026
SRZNSurrozen, Inc.$27M2.03%9.41%+44.3%Q4 2025
PTGXProtagonist Therapeutics, Inc$20.8M1.57%0.26%Not reportedQ2 2025
VIRVir Biotechnology, Inc.$19M1.43%1.10%Not reportedQ4 2025
PCVXVaxcyte, Inc.$18.9M1.42%0.22%Not reportedQ1 2026
URGNUroGen Pharma Ltd.$18.4M1.39%1.02%Not reportedQ2 2025
CRVSCorvus Pharmaceuticals, Inc.$16.4M1.24%1.31%Not reportedQ1 2026
PTCTPTC Therapeutics, Inc.$16.3M1.23%0.24%Not reportedQ3 2025
PRAXPraxis Precision Medicines, Inc.$15.6M1.17%0.17%Not reportedQ4 2025
AMLXAmylyx Pharmaceuticals, Inc.$14.4M1.08%0.72%Not reportedQ4 2024
OCULOcular Therapeutix, Inc$12.8M0.96%0.59%+271.4%Q1 2026
IRDOpus Genetics, Inc.$11.6M0.87%3.41%+25.1%Q1 2026
PALIPalisade Bio, Inc.$10M0.76%2.77%Not reportedQ4 2025
APGEApogee Therapeutics, Inc.$9.29M0.70%0.09%Not reportedQ4 2024
SYRESpyre Therapeutics, Inc.$8.88M0.67%0.11%Not reportedQ4 2024
COGTCogent Biosciences, Inc.$8.71M0.66%0.13%Not reportedQ4 2025
CYTKCytokinetics Inc$8.52M0.64%0.08%Not reportedQ3 2025
RLAYRelay Therapeutics, Inc.$8.42M0.63%0.21%Not reportedQ4 2024
CBIOCrescent Biopharma, Inc.$8.17M0.62%1.63%Not reportedQ2 2025
CTNMContineum Therapeutics, Inc.$8.1M0.61%2.14%Not reportedQ4 2025
KZIAKazia Therapeutics Ltd$7.88M0.59%0.07%NewQ2 2026
STTKShattuck Labs, Inc.$6.94M0.52%0.99%NewQ2 2026
AVTXAvalo Therapeutics, Inc.$6.93M0.52%0.71%+25.0%Q3 2025
FBRXForte Biosciences, Inc.$5.83M0.44%1.34%NewQ2 2026
RLMDRelmada Therapeutics, Inc.$5.83M0.44%0.79%Not reportedQ1 2026
MLTXMoonLake Immunotherapeutics$5.35M0.40%0.37%Not reportedQ3 2025
ZURAZura Bio Ltd$5.31M0.40%0.94%Not reportedQ4 2024
HELPCybin Inc.$5.22M0.39%1.53%+23.4%Q4 2025
ODTXOdyssey Therapeutics, Inc.$5.15M0.39%0.57%NewQ2 2026
IMTXImmatics N.V.$4.81M0.36%0.35%NewQ2 2026
FTHFaeth Therapeutics, Inc.$4.51M0.34%0.70%NewQ2 2026
GPCRStructure Therapeutics Inc.$4.03M0.30%0.04%Not reportedQ4 2024
ORICOric Pharmaceuticals, Inc.$3.79M0.29%0.34%+98.3%Q4 2024
ANTXAN2 Therapeutics, Inc.$3.63M0.27%2.06%Not reportedQ1 2026
NMRANeumora Therapeutics, Inc.$3.4M0.26%1.08%NewQ2 2026
INOInovio Pharmaceuticals, Inc.$3.13M0.24%3.46%+20.0%Q3 2025
ALLOAllogene Therapeutics, Inc.$3.12M0.23%0.43%-45.0%Q1 2026
SLDBSolid Biosciences Inc.$3M0.23%0.29%Not reportedQ1 2025
Q1 2026Reported May 15, 202653 positions
TNGXTango Therapeutics, Inc.$228M29.87%7.54%Not reportedQ4 2024
KODKodiak Sciences Inc.$51.9M6.81%2.19%+19.8%Q4 2024
RVMDRevolution Medicines, Inc.$48.6M6.38%0.25%+25.0%Q4 2024
KYMRKymera Therapeutics, Inc.$27.4M3.60%0.40%Not reportedQ4 2024
CELCCelcuity Inc.$25.7M3.37%0.47%Not reportedQ3 2025
SRZNSurrozen, Inc.$22.3M2.93%6.67%+84.1%Q4 2025
ABVXAbivax S.A.$22.3M2.92%0.25%+60.0%Q3 2025
TERNTerns Pharmaceuticals, Inc.$19.8M2.60%0.32%Not reportedQ4 2024
PCVXVaxcyte, Inc.$18.9M2.48%0.23%NewQ1 2026
CAPRCapricor Therapeutics, Inc.$17.9M2.35%1.02%+81.5%Q4 2025
PTGXProtagonist Therapeutics, Inc$17.9M2.35%0.26%Not reportedQ2 2025
VIRVir Biotechnology, Inc.$16.7M2.20%1.16%+198.6%Q4 2025
CRVSCorvus Pharmaceuticals, Inc.$16.1M2.11%1.31%NewQ1 2026
PRAXPraxis Precision Medicines, Inc.$15M1.97%0.17%Not reportedQ4 2025
PTCTPTC Therapeutics, Inc.$13.6M1.79%0.24%Not reportedQ3 2025
PGENPrecigen, Inc.$13.5M1.78%0.98%+154.6%Q3 2025
DFTXDefinium Therapeutics, Inc.$11.3M1.49%0.58%NewQ1 2026
AMLXAmylyx Pharmaceuticals, Inc.$11.1M1.46%0.72%Not reportedQ4 2024
QUREuniQure N.V.$10.8M1.42%1.05%+128.3%Q4 2024
IRDOpus Genetics, Inc.$10.2M1.34%3.15%NewQ1 2026
CORTCorcept Therapeutics Inc$10.1M1.32%0.24%NewQ1 2026
URGNUroGen Pharma Ltd.$8.99M1.18%1.03%Not reportedQ2 2025
REPLReplimune Group, Inc.$8.99M1.18%1.42%+56.7%Q4 2024
COGTCogent Biosciences, Inc.$8.66M1.14%0.13%Not reportedQ4 2025
PALIPalisade Bio, Inc.$8.4M1.10%2.87%Not reportedQ4 2025
CBIOCrescent Biopharma, Inc.$8.33M1.09%1.65%Not reportedQ2 2025
SLNOSoleno Therapeutics Inc$6.7M0.88%0.39%NewQ1 2026
ALLOAllogene Therapeutics, Inc.$6.65M0.87%1.11%NewQ1 2026
CYTKCytokinetics Inc$6.59M0.87%0.08%Not reportedQ3 2025
CTNMContineum Therapeutics, Inc.$6.45M0.85%2.14%Not reportedQ4 2025
APGEApogee Therapeutics, Inc.$5.89M0.77%0.09%Not reportedQ4 2024
RLMDRelmada Therapeutics, Inc.$5.86M0.77%0.80%NewQ1 2026
ZURAZura Bio Ltd$5.36M0.70%0.95%+1700.0%Q4 2024
MLTXMoonLake Immunotherapeutics$5.13M0.67%0.52%Not reportedQ3 2025
AVTXAvalo Therapeutics, Inc.$4.48M0.59%1.22%+9.1%Q3 2025
INOInovio Pharmaceuticals, Inc.$4.12M0.54%3.40%-2.1%Q3 2025
GPCRStructure Therapeutics Inc.$3.62M0.47%0.04%Not reportedQ4 2024
SRPTSarepta Therapeutics, Inc.$3.26M0.43%0.14%Not reportedQ2 2025
HELPCybin Inc.$3.07M0.40%1.24%-10.5%Q4 2025
OCULOcular Therapeutix, Inc$2.96M0.39%0.16%NewQ1 2026
ANTXAN2 Therapeutics, Inc.$2.56M0.34%2.08%NewQ1 2026
CLNNClene Inc.$2.35M0.31%4.05%+139.1%Q4 2025
ORICOric Pharmaceuticals, Inc.$2.24M0.29%0.17%Not reportedQ4 2024
SLDBSolid Biosciences Inc.$2.16M0.28%0.30%Not reportedQ1 2025
IVVDInvivyd, Inc.$1.95M0.26%0.53%Not reportedQ4 2025
LBRXLB Pharmaceuticals Inc$1.73M0.23%0.24%Not reportedQ3 2025
KPTIKaryopharm Therapeutics Inc.$1.69M0.22%1.34%+19.8%Q4 2025
NRIXNurix Therapeutics, Inc.$1.55M0.20%0.10%Not reportedQ4 2024
UPBUpstream Bio, Inc.$1.35M0.18%0.28%Not reportedQ4 2025
MISTMilestone Pharmaceuticals Inc.$793K0.10%0.57%Not reportedQ4 2024
Q4 2025Reported Feb 17, 202644 positions
TNGXTango Therapeutics, Inc.$96.4M21.09%8.00%+11.3%Q4 2024
RVMDRevolution Medicines, Inc.$31.9M6.97%0.20%Not reportedQ4 2024
KODKodiak Sciences Inc.$31.8M6.95%1.84%+51.5%Q4 2024
KYMRKymera Therapeutics, Inc.$25.6M5.60%0.40%+3.1%Q4 2024
CELCCelcuity Inc.$22.4M4.91%0.47%+150.0%Q3 2025
ABVXAbivax S.A.$16.9M3.69%0.16%+4.2%Q3 2025
PTCTPTC Therapeutics, Inc.$15.2M3.33%0.25%Not reportedQ3 2025
TERNTerns Pharmaceuticals, Inc.$15.2M3.32%0.33%Not reportedQ4 2024
PTGXProtagonist Therapeutics, Inc$14.8M3.25%0.27%+54.6%Q2 2025
PRAXPraxis Precision Medicines, Inc.$13.7M3.00%0.18%NewQ4 2025
URGNUroGen Pharma Ltd.$11.7M2.56%1.03%-13.0%Q2 2025
CDTXCidara Therapeutics, Inc.$11.7M2.56%0.17%+10.4%Q2 2025
PALIPalisade Bio, Inc.$11.3M2.47%3.01%NewQ4 2025
AMLXAmylyx Pharmaceuticals, Inc.$9.66M2.12%0.73%-11.1%Q4 2024
SRZNSurrozen, Inc.$9.4M2.06%4.26%NewQ4 2025
CAPRCapricor Therapeutics, Inc.$9.38M2.05%0.57%NewQ4 2025
MNMDDefinium Therapeutics, Inc.$8.01M1.75%Not reported+266.1%Q3 2025
COGTCogent Biosciences, Inc.$7.99M1.75%0.14%NewQ4 2025
REPLReplimune Group, Inc.$7.29M1.60%0.94%-28.6%Q4 2024
QUREuniQure N.V.$6.94M1.52%0.47%-63.8%Q4 2024
CYTKCytokinetics Inc$6.35M1.39%0.08%-50.0%Q3 2025
HELPCybin Inc.$5.85M1.28%3.31%NewQ4 2025
PGENPrecigen, Inc.$5.75M1.26%0.39%+61.8%Q3 2025
CTNMContineum Therapeutics, Inc.$5.65M1.24%2.14%NewQ4 2025
CBIOCrescent Biopharma, Inc.$5.38M1.18%1.65%Not reportedQ2 2025
APGEApogee Therapeutics, Inc.$5.28M1.16%0.10%+40.0%Q4 2024
GPCRStructure Therapeutics Inc.$5.22M1.14%0.04%Not reportedQ4 2024
AVTXAvalo Therapeutics, Inc.$4.99M1.09%1.49%+120.0%Q3 2025
INOInovio Pharmaceuticals, Inc.$4.21M0.92%3.51%+5.2%Q3 2025
UPBUpstream Bio, Inc.$4.07M0.89%0.28%NewQ4 2025
VIRVir Biotechnology, Inc.$3.77M0.82%0.45%NewQ4 2025
IVVDInvivyd, Inc.$3.71M0.81%0.53%NewQ4 2025
MLTXMoonLake Immunotherapeutics$3.62M0.79%0.52%+10.0%Q3 2025
SRPTSarepta Therapeutics, Inc.$3.23M0.71%0.14%-40.0%Q2 2025
PEPGPepGen Inc.$2.43M0.53%0.54%+49.6%Q3 2025
NRIXNurix Therapeutics, Inc.$1.9M0.42%0.10%-42.9%Q4 2024
KPTIKaryopharm Therapeutics Inc.$1.86M0.41%1.38%NewQ4 2025
SLDBSolid Biosciences Inc.$1.69M0.37%0.38%-50.0%Q1 2025
LBRXLB Pharmaceuticals Inc$1.56M0.34%0.28%Not reportedQ3 2025
MISTMilestone Pharmaceuticals Inc.$1.35M0.29%0.63%Not reportedQ4 2024
CLNNClene Inc.$1.17M0.26%1.84%NewQ4 2025
KALVKalVista Pharmaceuticals, Inc.$329K0.07%0.04%Not reportedQ4 2024
ZURAZura Bio Ltd$262K0.06%0.07%Not reportedQ4 2024
NUVBNuvation Bio Inc.$88K0.02%0.08%Not reportedQ4 2024
Q3 2025Reported Feb 17, 202633 positions
TNGXTango Therapeutics, Inc.$82.1M26.16%8.76%Not reportedQ4 2024
QUREuniQure N.V.$46.7M14.88%1.29%-11.1%Q4 2024
RVMDRevolution Medicines, Inc.$18.7M5.95%0.21%-49.6%Q4 2024
KYMRKymera Therapeutics, Inc.$18.1M5.76%0.44%-26.1%Q4 2024
KODKodiak Sciences Inc.$12.3M3.91%1.42%Not reportedQ4 2024
PTCTPTC Therapeutics, Inc.$12.3M3.91%0.25%NewQ3 2025
AMLXAmylyx Pharmaceuticals, Inc.$12.2M3.90%0.82%-26.5%Q4 2024
URGNUroGen Pharma Ltd.$11.5M3.66%1.23%Not reportedQ2 2025
MRUSMerus N.V.$11.3M3.60%0.16%-67.1%Q4 2024
CYTKCytokinetics Inc$11M3.50%0.17%NewQ3 2025
ABVXAbivax S.A.$10.2M3.25%0.19%NewQ3 2025
PTGXProtagonist Therapeutics, Inc$7.31M2.33%0.18%+83.3%Q2 2025
NKTRNektar Therapeutics$7.11M2.27%0.64%Not reportedQ2 2025
CBIOCrescent Biopharma, Inc.$5.39M1.72%3.27%Not reportedQ2 2025
INOInovio Pharmaceuticals, Inc.$5.38M1.72%4.29%NewQ3 2025
SRPTSarepta Therapeutics, Inc.$4.82M1.54%0.24%+900.0%Q2 2025
CDTXCidara Therapeutics, Inc.$4.6M1.47%0.16%-12.7%Q2 2025
CELCCelcuity Inc.$4.45M1.42%0.21%NewQ3 2025
REPLReplimune Group, Inc.$4.4M1.40%1.34%-52.5%Q4 2024
SLDBSolid Biosciences Inc.$3.7M1.18%0.77%Not reportedQ1 2025
DNLIDenali Therapeutics Inc.$3.63M1.16%0.17%Not reportedQ1 2025
PGENPrecigen, Inc.$2.8M0.89%0.24%NewQ3 2025
APGEApogee Therapeutics, Inc.$1.99M0.63%0.08%Not reportedQ4 2024
MNMDDefinium Therapeutics, Inc.$1.93M0.61%Not reportedNewQ3 2025
MLTXMoonLake Immunotherapeutics$1.79M0.57%0.47%NewQ3 2025
NRIXNurix Therapeutics, Inc.$1.62M0.52%0.23%Not reportedQ4 2024
AVTXAvalo Therapeutics, Inc.$1.59M0.51%0.70%NewQ3 2025
MISTMilestone Pharmaceuticals Inc.$1.33M0.42%0.78%Not reportedQ4 2024
PEPGPepGen Inc.$1.16M0.37%0.76%NewQ3 2025
LBRXLB Pharmaceuticals Inc$1.11M0.35%0.28%NewQ3 2025
TILInstil Bio, Inc.$1.08M0.35%0.90%-14.1%Q4 2024
KALVKalVista Pharmaceuticals, Inc.$248K0.08%0.04%-78.2%Q4 2024
NUVBNuvation Bio Inc.$53.9K0.02%0.08%Not reportedQ4 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.